Abstracts
Identifieur interne : 002B88 ( Main/Exploration ); précédent : 002B87; suivant : 002B89Abstracts
Auteurs :Source :
- Human & Experimental Toxicology [ 0960-3271 ] ; 1995-10.
English descriptors
- Teeft :
- Aflatoxin, Agonist, Agonist binding, Alcohol dehydrogenase, Alcoholic, Alcoholic liver disease, Aldehyde, Aldehyde dehydrogenase, Aldh3, Alko group, Anttila, Asbestos, Asbestos cement workers, Asbestos fibres, Assay, Basal treatment state, Benzalkonium chloride, Bind covalently, Biochemical interactions, Biological monitoring, Blood alcohol, Blood ethanol concentration, Blue colour, Body weight, Breast cancer, Breast cancer patients, Bronchial muscle, Carbon tetrachloride, Carcinogenesis, Carcinogenic, Carcinogenic action, Carcinogenic pahs, Carcinoma, Cell division, Cell membrane, Cell viability, Cellular uptake, Chemical form, Chlorinated aliphatic hydrocarbons, Chlorine atom, Cholinergic precontraction, Chronic citalopram, Chronic fluoxetine treatment, Chronic metformin treatment, Ciliary, Ciliary activity, Citalopram, Clin pharmacol, Clinical pharmacology, Clinical trials, Clodronate, Clofibrate, Control activity, Control groups, Coumarin, Coumarin index, Cruciferous vegetables, Culture medium, Cytochrome, Cytochrome enzymes, Degradation products, Dehydrogenase, Dgge, Dgge assay, Dioxin, Dioxin receptor, Direct sequencing, Distinct responses, Dos, Dose levels, Drug metabolism, Eicosanoid synthesis, Environmental health, Environmental medicine, Enzyme, Enzyme activities, Enzyme family, Enzymes catalyze, Epileptic patients, Equimolar doses, Ethanol, Ethylene, Ethylene glycol, Ethylene glycol intoxication, Experimental atherosclerosis, External dose, Felbamate, Felbamate treatment, Female rats, Fetal liver, Fibre, Fibre doses, Finland, Finnish, Finnish institute, Finnish population, First network meeting, Fluoxetine, Fluoxetine treatments, Forensic medicine, Formaldehyde, Genetic basis, Genetic polymorphism, Genetic susceptibility, Genetic variation, Genotype, Glucose transporter proteins, Glucuronidation, Glucuronidation activities, Glucuronidation rate, Glutathione, Glycol, Gstm1, Gstmi, Gstmi gene, Gstt1 genotypes, Gstti, Gstti gene, Guideline, Guinea, Guinea pigs, Harri vainio finnish institute, Harvard university press, Health institute, Healthy women, Helsinki, Helsinki university, Heme arginate, Hepatic, Human liver, Human lung microsomes, Human lungs, Human mesothelial cells, Incubation mixture, Individual susceptibility, Inhibitor, Initial activation, Inositol phosphates, Integral part, Interspecific variation, Intoxication, Intracellular, Kidney failure, Kinetics, Kuopio, Last dose, Lesion, Ligand, Liver, Liver microsomes, Liver type, Lung cancer, Lung cancer patients, Lung cancer risk, Lysosomal, Lysosomal enzymes, Lysosomal enzymes cathepsin, Lysosomal functions, Macrophage, Major importance, Male wistar rats, Medical school, Mesothelial, Mesothelial cells, Metabolic, Metabolism, Metabolite, Metformin, Microsomal protein, Microsome, Moldy houses, Monomeric form, Mrna, Mrna levels, Muscle strips, Mutation, Nasal mucus, National institute, Nervous system, Neural cell membranes, Neuronal cells, Nitric, Nitric oxide, Nitric oxide donors, Nitrite levels, Noradrenaline, Nordic, Nordic cooperation, Nordic laboratories, Occupational health, Occupational hygiene, Organic solvents, Orion corporation, Other hand, Other macromolecules, Oulu, Outer segments, Oxidant damage, Oxidative, Oxidative burst, Oxidative metabolism, Pahs, Palatable food, Pbpk models, Pdbu binding, Peitc, Pelkonen, Peroxisome, Peroxisome proliferation, Peroxisome proliferators, Phagocyting cells, Pharmaceutical chemistry division, Pharmacology, Phenethyl isothiocyanate, Pilocarpine, Plasma membrane, Pleural abnormalities, Pleural plaques, Polymorphic, Polymorphism, Possible role, Present study, Previous studies, Probe drugs, Prostacyclin productions, Protein content, Protein kinase, Protein synthesis, Public health, Public health institute, Pyrene, Pyrene activity, Rat, Reactive metabolites, Recent findings, Receptor, Receptor function, Recombinant, Recombinant yeast cells, Respiratory tract, Results show, Retinal pigment epithelium, Risk estimates, Severe acidosis, Significant differences, Significant effect, Single dose, Single treatment, Skeletal muscle, Slight increase, Smoker, Smooth muscle, Solvent, Southern finland, Squamous cell carcinoma, Standard species, Strong liver carcinogen, Subcellular fractions, Susceptibility, Syndrome, Tahti university, Tamoxifen, Tampere, Target dose, Target genes, Target tissue, Tcdd, Therapeutic efficacy, Tobacco smoking, Toremifene, Total cell number, Toxic, Toxic effect, Toxic effects, Toxicity, Toxicity testing, Toxicity testing areas, Toxicology, Tumor necrosis factor, Tumour, Turku, Urinary excretion, Urine, Urine samples, Vainio, Variegate porphyria, Various extrahepatic tissues, Vegan, Viability, Vitreous fibres, Vivo, Volume density, Western blot, Wide interindividual variation, World health organization, Yeast cells, Zucker, Zucker rats.
Url:
DOI: 10.1177/096032719501401009
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001937
- to stream Istex, to step Curation: 001937
- to stream Istex, to step Checkpoint: 001979
- to stream Main, to step Merge: 002C46
- to stream Main, to step Curation: 002B88
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstracts</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:91BAE757CCCA096D5AD9780A4EC038E5EC580578</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1177/096032719501401009</idno>
<idno type="url">https://api.istex.fr/ark:/67375/M70-ZMQFXVHV-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001937</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001937</idno>
<idno type="wicri:Area/Istex/Curation">001937</idno>
<idno type="wicri:Area/Istex/Checkpoint">001979</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001979</idno>
<idno type="wicri:Area/Main/Merge">002C46</idno>
<idno type="wicri:Area/Main/Curation">002B88</idno>
<idno type="wicri:Area/Main/Exploration">002B88</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Abstracts</title>
</analytic>
<monogr></monogr>
<series><title level="j">Human & Experimental Toxicology</title>
<idno type="ISSN">0960-3271</idno>
<idno type="eISSN">1477-0903</idno>
<imprint><publisher>Sage Publications</publisher>
<pubPlace>Sage CA: Thousand Oaks, CA</pubPlace>
<date type="published" when="1995-10">1995-10</date>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="820">820</biblScope>
<biblScope unit="page" to="845">845</biblScope>
</imprint>
<idno type="ISSN">0960-3271</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0960-3271</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Aflatoxin</term>
<term>Agonist</term>
<term>Agonist binding</term>
<term>Alcohol dehydrogenase</term>
<term>Alcoholic</term>
<term>Alcoholic liver disease</term>
<term>Aldehyde</term>
<term>Aldehyde dehydrogenase</term>
<term>Aldh3</term>
<term>Alko group</term>
<term>Anttila</term>
<term>Asbestos</term>
<term>Asbestos cement workers</term>
<term>Asbestos fibres</term>
<term>Assay</term>
<term>Basal treatment state</term>
<term>Benzalkonium chloride</term>
<term>Bind covalently</term>
<term>Biochemical interactions</term>
<term>Biological monitoring</term>
<term>Blood alcohol</term>
<term>Blood ethanol concentration</term>
<term>Blue colour</term>
<term>Body weight</term>
<term>Breast cancer</term>
<term>Breast cancer patients</term>
<term>Bronchial muscle</term>
<term>Carbon tetrachloride</term>
<term>Carcinogenesis</term>
<term>Carcinogenic</term>
<term>Carcinogenic action</term>
<term>Carcinogenic pahs</term>
<term>Carcinoma</term>
<term>Cell division</term>
<term>Cell membrane</term>
<term>Cell viability</term>
<term>Cellular uptake</term>
<term>Chemical form</term>
<term>Chlorinated aliphatic hydrocarbons</term>
<term>Chlorine atom</term>
<term>Cholinergic precontraction</term>
<term>Chronic citalopram</term>
<term>Chronic fluoxetine treatment</term>
<term>Chronic metformin treatment</term>
<term>Ciliary</term>
<term>Ciliary activity</term>
<term>Citalopram</term>
<term>Clin pharmacol</term>
<term>Clinical pharmacology</term>
<term>Clinical trials</term>
<term>Clodronate</term>
<term>Clofibrate</term>
<term>Control activity</term>
<term>Control groups</term>
<term>Coumarin</term>
<term>Coumarin index</term>
<term>Cruciferous vegetables</term>
<term>Culture medium</term>
<term>Cytochrome</term>
<term>Cytochrome enzymes</term>
<term>Degradation products</term>
<term>Dehydrogenase</term>
<term>Dgge</term>
<term>Dgge assay</term>
<term>Dioxin</term>
<term>Dioxin receptor</term>
<term>Direct sequencing</term>
<term>Distinct responses</term>
<term>Dos</term>
<term>Dose levels</term>
<term>Drug metabolism</term>
<term>Eicosanoid synthesis</term>
<term>Environmental health</term>
<term>Environmental medicine</term>
<term>Enzyme</term>
<term>Enzyme activities</term>
<term>Enzyme family</term>
<term>Enzymes catalyze</term>
<term>Epileptic patients</term>
<term>Equimolar doses</term>
<term>Ethanol</term>
<term>Ethylene</term>
<term>Ethylene glycol</term>
<term>Ethylene glycol intoxication</term>
<term>Experimental atherosclerosis</term>
<term>External dose</term>
<term>Felbamate</term>
<term>Felbamate treatment</term>
<term>Female rats</term>
<term>Fetal liver</term>
<term>Fibre</term>
<term>Fibre doses</term>
<term>Finland</term>
<term>Finnish</term>
<term>Finnish institute</term>
<term>Finnish population</term>
<term>First network meeting</term>
<term>Fluoxetine</term>
<term>Fluoxetine treatments</term>
<term>Forensic medicine</term>
<term>Formaldehyde</term>
<term>Genetic basis</term>
<term>Genetic polymorphism</term>
<term>Genetic susceptibility</term>
<term>Genetic variation</term>
<term>Genotype</term>
<term>Glucose transporter proteins</term>
<term>Glucuronidation</term>
<term>Glucuronidation activities</term>
<term>Glucuronidation rate</term>
<term>Glutathione</term>
<term>Glycol</term>
<term>Gstm1</term>
<term>Gstmi</term>
<term>Gstmi gene</term>
<term>Gstt1 genotypes</term>
<term>Gstti</term>
<term>Gstti gene</term>
<term>Guideline</term>
<term>Guinea</term>
<term>Guinea pigs</term>
<term>Harri vainio finnish institute</term>
<term>Harvard university press</term>
<term>Health institute</term>
<term>Healthy women</term>
<term>Helsinki</term>
<term>Helsinki university</term>
<term>Heme arginate</term>
<term>Hepatic</term>
<term>Human liver</term>
<term>Human lung microsomes</term>
<term>Human lungs</term>
<term>Human mesothelial cells</term>
<term>Incubation mixture</term>
<term>Individual susceptibility</term>
<term>Inhibitor</term>
<term>Initial activation</term>
<term>Inositol phosphates</term>
<term>Integral part</term>
<term>Interspecific variation</term>
<term>Intoxication</term>
<term>Intracellular</term>
<term>Kidney failure</term>
<term>Kinetics</term>
<term>Kuopio</term>
<term>Last dose</term>
<term>Lesion</term>
<term>Ligand</term>
<term>Liver</term>
<term>Liver microsomes</term>
<term>Liver type</term>
<term>Lung cancer</term>
<term>Lung cancer patients</term>
<term>Lung cancer risk</term>
<term>Lysosomal</term>
<term>Lysosomal enzymes</term>
<term>Lysosomal enzymes cathepsin</term>
<term>Lysosomal functions</term>
<term>Macrophage</term>
<term>Major importance</term>
<term>Male wistar rats</term>
<term>Medical school</term>
<term>Mesothelial</term>
<term>Mesothelial cells</term>
<term>Metabolic</term>
<term>Metabolism</term>
<term>Metabolite</term>
<term>Metformin</term>
<term>Microsomal protein</term>
<term>Microsome</term>
<term>Moldy houses</term>
<term>Monomeric form</term>
<term>Mrna</term>
<term>Mrna levels</term>
<term>Muscle strips</term>
<term>Mutation</term>
<term>Nasal mucus</term>
<term>National institute</term>
<term>Nervous system</term>
<term>Neural cell membranes</term>
<term>Neuronal cells</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Nitric oxide donors</term>
<term>Nitrite levels</term>
<term>Noradrenaline</term>
<term>Nordic</term>
<term>Nordic cooperation</term>
<term>Nordic laboratories</term>
<term>Occupational health</term>
<term>Occupational hygiene</term>
<term>Organic solvents</term>
<term>Orion corporation</term>
<term>Other hand</term>
<term>Other macromolecules</term>
<term>Oulu</term>
<term>Outer segments</term>
<term>Oxidant damage</term>
<term>Oxidative</term>
<term>Oxidative burst</term>
<term>Oxidative metabolism</term>
<term>Pahs</term>
<term>Palatable food</term>
<term>Pbpk models</term>
<term>Pdbu binding</term>
<term>Peitc</term>
<term>Pelkonen</term>
<term>Peroxisome</term>
<term>Peroxisome proliferation</term>
<term>Peroxisome proliferators</term>
<term>Phagocyting cells</term>
<term>Pharmaceutical chemistry division</term>
<term>Pharmacology</term>
<term>Phenethyl isothiocyanate</term>
<term>Pilocarpine</term>
<term>Plasma membrane</term>
<term>Pleural abnormalities</term>
<term>Pleural plaques</term>
<term>Polymorphic</term>
<term>Polymorphism</term>
<term>Possible role</term>
<term>Present study</term>
<term>Previous studies</term>
<term>Probe drugs</term>
<term>Prostacyclin productions</term>
<term>Protein content</term>
<term>Protein kinase</term>
<term>Protein synthesis</term>
<term>Public health</term>
<term>Public health institute</term>
<term>Pyrene</term>
<term>Pyrene activity</term>
<term>Rat</term>
<term>Reactive metabolites</term>
<term>Recent findings</term>
<term>Receptor</term>
<term>Receptor function</term>
<term>Recombinant</term>
<term>Recombinant yeast cells</term>
<term>Respiratory tract</term>
<term>Results show</term>
<term>Retinal pigment epithelium</term>
<term>Risk estimates</term>
<term>Severe acidosis</term>
<term>Significant differences</term>
<term>Significant effect</term>
<term>Single dose</term>
<term>Single treatment</term>
<term>Skeletal muscle</term>
<term>Slight increase</term>
<term>Smoker</term>
<term>Smooth muscle</term>
<term>Solvent</term>
<term>Southern finland</term>
<term>Squamous cell carcinoma</term>
<term>Standard species</term>
<term>Strong liver carcinogen</term>
<term>Subcellular fractions</term>
<term>Susceptibility</term>
<term>Syndrome</term>
<term>Tahti university</term>
<term>Tamoxifen</term>
<term>Tampere</term>
<term>Target dose</term>
<term>Target genes</term>
<term>Target tissue</term>
<term>Tcdd</term>
<term>Therapeutic efficacy</term>
<term>Tobacco smoking</term>
<term>Toremifene</term>
<term>Total cell number</term>
<term>Toxic</term>
<term>Toxic effect</term>
<term>Toxic effects</term>
<term>Toxicity</term>
<term>Toxicity testing</term>
<term>Toxicity testing areas</term>
<term>Toxicology</term>
<term>Tumor necrosis factor</term>
<term>Tumour</term>
<term>Turku</term>
<term>Urinary excretion</term>
<term>Urine</term>
<term>Urine samples</term>
<term>Vainio</term>
<term>Variegate porphyria</term>
<term>Various extrahepatic tissues</term>
<term>Vegan</term>
<term>Viability</term>
<term>Vitreous fibres</term>
<term>Vivo</term>
<term>Volume density</term>
<term>Western blot</term>
<term>Wide interindividual variation</term>
<term>World health organization</term>
<term>Yeast cells</term>
<term>Zucker</term>
<term>Zucker rats</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B88 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B88 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:91BAE757CCCA096D5AD9780A4EC038E5EC580578 |texte= Abstracts }}
This area was generated with Dilib version V0.6.33. |